Routine board appointment with no earnings, guidance, or strategic pivot. No actionable trading signal — monitor next quarterly earnings for any operational updates.
Price Chart
Executive Summary
Alkermes appointed Anne C. Whitaker as an independent director, expanding the board from 10 to 11 members. Ms. Whitaker is a seasoned biopharmaceutical executive with prior CEO experience and current board seats at ICON plc and Basilea Pharmaceutica. The filing is a routine board appointment with no material financial impact — no financial results, guidance, or strategic changes were disclosed.
Key Facts
- Board expanded from 10 to 11 directors with the appointment of Anne C. Whitaker.
- Ms. Whitaker will receive an initial equity award with an aggregate target value of $600,000, split 50% stock options and 50% RSUs, vesting over three years.
- Ms. Whitaker is an independent director with no prior transactions with the company since January 1, 2025.
- The appointment is effective September 14, 2026, with a term expiring at the 2027 annual general meeting.
Financial Impact
Initial director equity award of $600,000 in aggregate target value — immaterial relative to a $7.7B market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-392527 |
| Document: alks-ex99_1.htm | 0001193125-26-392527 |
| Document: 0001193125-26-392527-index-headers.html | 0001193125-26-392527 |
| Document: 0001193125-26-392527-index.html | 0001193125-26-392527 |
| Document: 0001193125-26-392527.txt | 0001193125-26-392527 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | 8-K | $46.07 $42.13 | ▼ −8.55% | ▼ −11.12% | $41.75 (−9.38%) |
Sep 3, 2026 28d ago | Insider Cluster | $46.10 $45.83 | ▼ −0.59% | ▲ +0.62% | $41.75 (−9.44%) |
Aug 3, 2026 8w ago | Insider Cluster | $49.67 $49.21 | ▲ +0.93% | ▲ +0.83% | $41.75 (+15.95%) |
Aug 3, 2026 8w ago | Insider Cluster | $49.67 $49.21 | ▼ −0.93% | ▼ −0.83% | $41.75 (−15.95%) |
Aug 3, 2026 8w ago | Insider Cluster | $49.67 $49.21 | ▼ −0.93% | ▼ −0.83% | $41.75 (−15.95%) |
Jul 28, 2026 9w ago | 8-K | $50.50 $49.53 | ▲ +1.92% | ▲ +4.19% | $41.75 (+17.33%) |
Jul 8, 2026 12w ago | 8-K | $54.29 $51.60 | ▼ −4.95% | ▼ −5.82% | $41.75 (−23.10%) |
Jul 6, 2026 12w ago | Insider Cluster | $55.14 $51.94 | ▼ −5.80% | ▼ −6.29% | $41.75 (−24.28%) |
Jun 4, 2026 17w ago | Insider Cluster | $42.80 $44.28 | ▲ +3.46% | ▲ +2.89% | $41.75 (−2.45%) |
Jun 1, 2026 17w ago | Insider Cluster | $41.19 $44.29 | ▲ +7.53% | ▲ +10.50% | $41.75 (+1.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access